Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesOrgenesis Inc

Orgenesis Inc

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.4 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
100
Market Cap
5.78M

Momentum Score

…

Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.40
Low
0.91
High
52 Week Price Range
0.00
Low
1.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.40
Dividend Yield
-
Revenue TTM
1.03M
Revenue Per Share
0.25
Gross Profit TTM
-0.89M
Debt / Equity
-1.08
ROE
-727.25%
Net Debt
16.61M
ROCE
101.94%
Diluted EPS TTM
-11.44

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2022-11-30 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2022-11-30 2021-12-31
Income before tax -48.92M -64.44M -11.96M -11.96M -17.95M
Minority interest 0.85M -3.22M -2.72M -2.72M 0.01M
Net income -48.16M -55.36M -14.89M -12.17M -18.06M
Selling general administrative 12.94M 34.62M 16.16M 16.16M 15.40M
Selling and marketing expenses - 0.46M 0.57M 0.57M 0.69M
Gross profit -8.47M -5.72M 15.59M 15.59M 7.34M
Reconciled depreciation 2.09M 1.88M 1.98M 1.98M 0.95M
Ebit - -62.28M -10.14M -7.37M -17.58M
Ebitda - -60.72M -8.16M -6.90M -15.72M
Depreciation and amortization - 1.56M 1.98M 0.47M 1.86M
Operating income -26.07M -53.64M -7.54M -7.37M -16.80M
Other operating expenses - 54.17M 46.13M 43.39M 52.30M
Interest expense 3.74M 2.17M 1.82M 1.82M 0.37M
Tax provision 0.10M 0.79M 0.21M 0.21M 0.11M
Net interest income -3.73M -2.50M -1.83M -1.83M -1.29M
Income tax expense - 0.47M 0.21M 0.21M 0.11M
Total revenue 1.03M 0.53M 36.02M 36.02M 35.50M
Total operating expenses 27.10M 47.91M 22.95M 22.95M 50.02M
Cost of revenue 9.51M 6.25M 20.44M 20.44M 28.16M
Total other income expense net -19.12M -10.81M -4.42M -4.59M -1.15M
Net income from continuing ops -49.01M -21.85M -12.17M -12.17M -18.06M
Net income applicable to common shares - - -14.89M -14.89M -18.05M
Breakdown 2024-12-31 2023-12-31 2023-11-30 2022-12-31 2022-11-30
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2023-11-30 2022-12-31 2022-11-30
Total assets 1.35M 14.55M 14.55M 90.93M 90.93M
Intangible assets - 7.38M 7.38M 9.69M 9.69M
Other current assets - 0.64M 3.12M 1.06M 4.70M
Total liab 38.88M 35.53M 35.53M 31.65M 31.65M
Total stockholder equity -37.50M -20.98M -20.98M 27.56M 27.56M
Other current liab - 5.53M 4.09M 4.51M 4.73M
Common stock - 0.00M 0.00M 0.00M 0.00M
Capital stock 0.01M 0.00M 0.00M 0.00M 0.00M
Retained earnings -224.79M -176.62M -176.62M -121.26M -121.26M
Other liab - - - 0.58M 0.58M
Good will 0.00M 1.21M 1.21M 8.19M 8.19M
Cash 0.08M 0.84M 0.84M 5.31M 5.31M
Total current liabilities 26.92M 16.41M 16.41M 15.91M 15.91M
Current deferred revenue - 2.18M 2.18M 1.58M 1.65M
Net debt 16.61M 21.78M 21.78M 14.96M 14.96M
Short term debt - 3.55M 3.55M 5.11M 5.11M
Short long term debt 8.22M 3.32M 3.32M 4.50M 4.50M
Short long term debt total - 22.62M 22.62M 20.27M 20.27M
Other stockholder equity - 155.57M 155.57M 149.09M 149.09M
Total current assets 0.76M 4.08M 4.08M 46.32M 46.32M
Long term investments 0.00M 0.01M 0.01M 0.14M 0.14M
Net tangible assets - - - 9.68M 9.68M
Net receivables 0.04M 2.56M 2.56M 39.83M 39.83M
Long term debt 8.47M 18.97M 18.97M 13.34M 13.34M
Inventory 0.00M 0.03M 0.03M 0.12M 0.12M
Accounts payable 10.43M 6.58M 6.58M 4.43M 4.43M
Accumulated other comprehensive income - 0.07M 0.07M -0.27M -0.27M
Non currrent assets other - 0.06M 0.02M 1.35M 1.35M
Non current assets total 0.59M 10.48M 10.48M 44.61M 44.61M
Capital lease obligations 1.57M 0.33M 0.33M 2.42M 2.42M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2022-11-30 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2022-11-30 2021-12-31
Investments - -12.07M -14.13M -14.13M -12.38M
Change to liabilities - - -0.69M -0.69M -3.32M
Total cashflows from investing activities - -3.71M -14.13M -14.13M -12.38M
Net borrowings 5.91M 3.33M 16.80M 16.80M -1.02M
Total cash from financing activities 15.96M 13.62M 39.58M 39.58M -0.11M
Change to operating activities - - 1.77M 1.77M 0.05M
Net income -48.16M -64.92M -12.17M -12.17M -18.06M
Change in cash -0.75M -4.89M 0.40M 0.40M -39.59M
Begin period cash flow 1.48M 6.37M 5.97M 5.97M 45.57M
End period cash flow 0.69M 1.48M 6.37M 6.37M 5.97M
Total cash from operating activities -17.08M -14.84M -24.92M -24.92M -26.87M
Issuance of capital stock 2.56M 5.52M 2.18M 2.18M 1.93M
Depreciation 2.09M 1.56M 1.98M 1.98M 1.86M
Other cashflows from investing activities - -1.58M -3.87M -3.61M -3.43M
Dividends paid - - - - 0.11M
Change to inventory 0.03M -0.39M -0.01M -0.01M 0.06M
Change to account receivables 0.13M 30.06M -21.05M -21.05M -12.18M
Sale purchase of stock - - -0.11M 0.00M -1.02M
Other cashflows from financing activities - 5.00M 20.59M 39.74M 0.21M
Change to netincome - - 7.97M 7.97M 4.72M
Capital expenditures 0.26M 2.10M 12.42M 12.42M 7.87M
Change in working capital 1.67M 36.63M -19.98M -19.98M -15.40M
Stock based compensation 3.19M 0.46M 0.98M 0.98M 1.75M
Other non cash items 2.79M 11.43M 4.37M 4.37M 0.50M
Free cash flow -17.34M -16.93M -37.34M -37.34M -34.73M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ORGS
Orgenesis Inc		 -
-%		 0.40 - - 5.59 1.26 23.15 -4.98
NVO
Novo Nordisk A/S		 0.01
0.02%		 40.31 41.58 31.15 2.13 32.99 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 4.59
0.85%		 547.09 30.22 24.27 10.36 6.50 9.99 24.66
REGN
Regeneron Pharmaceuticals Inc		 1.45
0.16%		 904.35 29.07 20.12 7.57 3.82 6.95 19.42
ARGNF
argenx SE		 -
-%		 900.30 45.77 31.25 13.84 7.12 11.38 36.06

Profile*

Orgenesis Inc

Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

20271 Goldenrod Lane, Germantown, MD, United States, 20876

480 659 6404

https://orgenesis.com

77

Name Title Year Born
Ms. Vered Caplan M.Sc. Chairperson of the Board, CEO & Pres 1969
Mr. Neil T. Reithinger CPA CFO, Sec. & Treasurer 1970
Dr. Efrat Assa Kunik Chief Devel. Officer 1975
Prof. Sarah Ferber Ph.D. Founder & Chief Scientific Officer 1954
Mr. Evan Fishman Chief Financial Officer NA
Dan Slonim COO & GM of Orgenesis Israel NA
Dr. Shimon Hassin Ph.D. Chief Technology Officer NA
Ms. Osher Partok Rheinisch Gen. Counsel & Compliance Officer NA
Mr. Vincent Vandamme Sr. VP of Quality Strategy NA
Ms. Vered Caplan M.Sc. Chairperson of the Board, CEO & President 1969

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…